Drug Eruption and Interactions - PHARMACEUTICAL REVIEW

Stevens–Johnson syndrome (1–10%)
(2007): Man CB+, Epilepsia 48(5), 1015
(2006): Hung SI+, Pharmacogenet Genomics 16(4), 297
(2006): Lonjou C+, Pharmacogenomics J 6(4), 265
(2005): Devi K+, Indian J Dermatol Venereol Leprol 71(5), 325
(2005): Lin MS+, Intern Med J 35(3), 188
(2005): Mockenhaupt M+, Neurology 64(7), 1134
(2004): Chung WH+, Nature 428(6982), 486
(2004): Lam NS+, J Microbiol Immunol Infect 37(6), 366
(2003): Feliciani C+, Int J Immunopathol Pharmacol 16(1), 89
(2002): Garcia M+, Dig Dis Sci 47(1), 177
(2001): Duggal HS+, J Assoc Physicians India 49, 591
(2001): Hebert AA+, J Clin Psychiatry 62(suppll4), 22
(2000): Ramadasan P+, J Assoc Physicians India 48(7), 742
(2000): Straussberg R+, Pediatr Neurol 22, 231
(2000): Suarez Moro R+, An Med Interna (Spanish) 17, 105
(1999): DeToledo JC+, Ther Drug Monit 21(1), 137
(1999): Dhar S+, Dermatology 199, 194
(1999): Petter G+, Hautarzt (German) 50, 884
(1999): Ruble R+, CNS Drugs 12, 215
(1999): Rzany B+, Lancet 353, 2190
(1995): Huang SC+, Gen Hosp Psychiatry 17, 458
(1995): Hughes-Davies L, NEnglJMed332, 959
(1995): Keating A+, Ann Pharmacother 29, 538
(1995): Wolkenstein P+, Arch Dermatol 131, 544
(1993): Konishi T+, Eur J Pediatr 152, 605
(1993): Leenutaphong V+, Int J Dermatol 32, 428
(1993): Pagliaro LA+, Hosp Community Psychiatry 44, 999
(1993): Server Climent M, Aten Primaria (Spanish) 11, 377
(1992): Chevenet C+, Ann Dermatol Venereol (French) 119, 929
(with brain irradiation)
(1990): Gebauer K+, Australas J Dermatol 31, 89 (passim)
(1990): Hoang-Xuan K+, Neurology 40, 1144 (with cranial
irradiation)
(1990): Khe HX+, Neurology 40, 1144
(1990): Roustan G+, Actas Dermosifiliogr (Spanish) 81, 775
(1990): Wong KE, Singapore Med J 31, 432
(1989): Alanko K+, Acta Derm Venereol (Stockh) 69, 223
(1988): McDanal CE, J Clin Psychiatr 49, 369
(1988): Warnock JK+, Am J Psychiatry 145, 425
(1987): Fawcett RG, J Clin Psychiatry 48, 416
Toxic epidermal necrolysis (1–10%)
(2006): Hung SI+, Pharmacogenet Genomics 16(4), 297
(2006): Lonjou C+, Pharmacogenomics J 6(4), 265
(2005): Devi K+, Indian J Dermatol Venereol Leprol 71(5), 325
(2005): Lin MS+, Intern Med J 35(3), 188
(2005): Mansouri P+, Arch Dermatol 141(6), 788 (with
lamotrigine)
(2004): Fischer M+, Klin Padiatr 216(5), 288
(2003): Feliciani C+, Int J Immunopathol Pharmacol 16(1), 89
(2002): Correia O+, Arch Dermatol 138, 29 (2 cases)
(2002): Jackel R+, Anaesthesist 51(10), 815
(2002): Kansky A+, Acta Dermatoven 11(3), 105
(2001): Udawat H+, J Assoc Physicians India 49, 918
(2000): Leyva L+, J Allergy Clin Immunol 105(1 Pt 1), 157
(1999): Dhar S+, Dermatology 199, 194
(1999): Egan CA+, JAmAcadDermatol40, 458
(1999): Petter G+, Hautarzt (German) 50, 884
(1999): Ruble R+, CNS Drugs 12, 215
(1999): Rzany B+, Lancet 353, 2190
(1997): Belgodere X+, Arch Pediatr (French) 4, 1020
(1997): Jarrett P+, Clin Exp Dermatol 22, 146
(1996): Blum L+, JAmAcadDermatol34, 1088
(1995): Sterker M+, Int J Clin Pharmacol Ther 33, 595
(1995): Urbanowski S+, Wiad Lek (Polish) 48, 154
(1995): Wolkenstein P+, Arch Dermatol 131, 544
(1994): Friedmann PS+, Arch Dermatol 130, 598
(1993): Correia O+, Dermatology 186, 32
(1993): Leenutaphong V+, Int J Dermatol 32, 428
(1993): Pagliaro LA+, Hospital and Community Psychiatry 44, 999
CARBAMAZEPINE 93
(1992): Park BK+, Br J Clin Pharmacol 34, 377
(1992): Weller M+, Am J Psychiatry 149, 1114
(1992): Weller M+, Nervenarzt (German) 63, 308
(1991): Sakellariou G+, Int J Artif Organs 14, 634
(1990): Gebauer K+, Australas J Dermatol 31, 89 (passim)
(1990): Roujeau JC+, Arch Dermatol 126, 37
(1988): Shear NH+, J Clin Invest 82, 1826
(1987): Guillaume JC+, Arch Dermatol 123, 1166
(1986): Rusciani L+, G Ital Dermatol Venereol (Italian) 121, 149
(1984): Husegaard HC+, Ugeskr Laeger (Danish) 146, 2784
(1984): Staughton RCD+, JRSocMed77 (Suppl 4), 6
(1982): Breathnach SM+, Clin Exp Dermatol 7, 585
Toxic pustuloderma (probably AGEP [ed])
(1990): Gebauer K+, Australas J Dermatol 31, 89
(1988): Commens CA+, Arch Dermatol 124, 178
(1984): Staughton RCD+, JRSocMed77 (Suppl 4), 6
Toxic-allergic shock
Toxicoderma
(1983): Rozov VD+, Vestn Dermatol Venerol (Russian)
September, 48
Urticaria
(2001): Hebert AA+, J Clin Psychiatry 62(suppl 14), 22
(1993): Alanko K, Contact Dermatitis 29, 254
(1993): Konishi T+, Eur J Pediatr 152, 605
(1990): Gebauer K+, Australas J Dermatol 31, 89 (passim)
(1988): Warnock JK+, Am J Psychiatry 145, 425
(1987): Johannessen AC+, Ugeskr Laeger (Danish) 149, 376
(1984): Staughton RCD+, JRSocMed77 (Suppl 4), 6
Vasculitis
(1993): Drory VE+, Clin Neuropharmacol 16, 19 (passim)
(1990): Gebauer K+, Australas J Dermatol 31, 89 (passim)
(1987): Harats N+, J Neurol Neurosurg Psychiatry 50, 1241
Mucosal
Glossitis
Mucocutaneous eruption
(1999): Edwards SG+, Postgrad Med J 75, 680
(1993): Konishi T+, Eur J Pediatr 152, 605
Mucocutaneous lymph node syndrome (Kawasaki
syndrome)
(1990): Gebauer K+, Australas J Dermatol 31, 89 (passim)
(1987): Hicks RA+, Pediatr Infect Dis J 7, 525
Oral lichenoid eruption
(1989): Ohtsuyama M+, Nishinihon J Dermatol (Japanese)
51, 958
Oral mucosal eruption
Oral ulceration
(2003): Misra UK+, Postgrad Med J 79(938), 703 (with
phenytoin)
(2001): Hebert AA+, J Clin Psychiatry 62(suppl 14), 22
Stomatitis
Tongue ulceration
(1998): Melgarejo Moreno PJ+, An Otorrinolaringol Ibero Am
(Spanish) 25, 167
Xerostomia
Hair
Hair – alopecia
(2000): Mercke Y+, Ann Clin Psychiatry 12, 35 (~6%)
(1997): Ikeda A+, J Neurol Neurosurg Psychiatry 63, 549
(1996): McKinney PA+, Ann Clin Psychiatry 8, 183
(1988): Warnock JK+, Am J Psychiatry 145, 425
(1985): Shuper A+, Drug Intell Clin Pharm 19, 924
(1982): Breathnach SM+, Clin Exp Dermatol 7, 585
Nails
Nails – discoloration (bluish-black)
(1989): Mishra D+, Int J Dermatol 28, 460
Nails – hypoplasia
(1985): Niesen M+, Neuropediatrics 16, 167